Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3793-3796

  Hajjar, Ramzi R ^a   Kaiser, Fran E ^a   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NITROGEN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; UREA;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LONG TERM CARE; MALE; PHLEBOTOMY; POLYCYTHEMIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030694397     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4387     Document Type: Article

References (41)

1. Baker HG, Burger HG, de Krester DM, et al. 1967 Changes in the pituitary testicular system with age. Clin Endocrinol (Oxf). 5:349-372.
2. Davidson J, Chen JJ, Crapo L, Gary GD, Greenleaf WJ, Catania JA. 1983 Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab. 57:71-77.
3. Desylpere JP, Vermeulen A. 1984 Leydig cell function in normal men: effect of age, lifestyle, residency, diet and activity. J Clin Endocrinol Metab. 59:955-962.
4. Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. 1988 Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc. 36:511-519.
5. Nankin HR, Calkin JG. 1986 Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab. 63:1418-1420.
6. Stearns EL, MacDonnel JA, Kaufman BL, et al. 1974 Declining testicular function with age: hormonal and clinical correlates. Am J Med. 57:761-766.
7. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ. 1987 The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomphene citrate. J Clin Endocrinol Metab. 65:1118-1126.
8. Morley JE, Solomon DH. 1990 The new geriatrics. J Am Geriatr Soc. 38:1373-1378.
9. Nunez AA. 1982 Dose dependent effects of testosterone on feeding and body weight in male rats. Behav Neurol Biol. 34:445-449.
10. Vermeulen A. 1991 Androgens in the aging male. J Clin Endocrinol Metab. 73:221-224.
11. Korenman SG, Morley JE, Mooradian AD, et al. 1990 Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab. 71:963-969.
12. Slag MF, Morley JE, Elson MK, et al. 1983 Impotence in medical clinic outpatients. JAMA. 249:1736-1740.
13. Warner BA, Dufau ML, Santen RJ. 1985 Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone. J Clin Endocrinol Metab. 60:263-268.
14. Winters SJ, Troen P. 1982 Episodic luteinizing hormone (LH) secretion, and the response of LH and follicle-stimulating hormone to LH releasing hormone in aged men: evidence of coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab. 55:560-565.
15. Plymate S. 1994 Hypogonadism. Endocrinol Metab Clin North Am. 23:749-772.
16. Neaves WB, Johnson L, Porter JC, et al. 1984 Leydig cell number, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab. 59:756-763.
17. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 75:1092-1098.
18. Morley JE, Perry HM, Kaiser FE, et al. 1993 Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 41:149-152.
19. Krauss DJ, Taub HA, Lantinga LJ, et al. 1991 Risk of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol. 146:1566-1570.
20. Sih R, Perry III HM, Kaiser FE, Patrick P, Roos C, Morley JE. 1995 Testosterone therapy increases strength in older hypogonadal men. J Invest Med. 43:300A.
21. Urban RJ, Bodenburg YH, Gilkeson C, et al. 1995 Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 269:E820-E826.
22. Drinka PJ, Joehem AL, Cuissnier M, Bloom R, Rudman I, Rudman D. 1995 Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone. J Am Geriatr Soc. 43:899-901.
23. Reed IR, Wattie DJ, Evans MC, Stapelton JP. 1996 Testosterone therapy in glucocorticoid-treated men. Arch Intern Med. 156:1173-1177.
24. Hartnell J, Korenman SG, Viosca SP. Results of testosterone enanthate therapy for hypogonadism in older men. Proc of the 72nd Annual Meet of The Endocrine Soc. 1990; 428.
25. Hajjar RR, Kaiser FE, Morley JE, Houston K. 1995 Outcomes of long term testosterone treatment in older males. J Am Geriatr Soc. 43:SA23.
26. Schulte-Beerbuhl M, Nieschlag E. 1980 Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertil Steril. 33:201-203.
27. Nankin HR. 1987 Hormone kinetics after intramuscular testosterone cypionate. Fertil Steril. 47:1004-1009.
28. Barry MJ, Fowler FJ, O'Leary MP, et al. 1992 The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 148:1549-1557.
29. Mooradian AD, Morley JE, Korenman SG. 1987 Biological actions of androgens. Endocr Rev. 8:1-28.
30. Krabbe S, Christensen T, Worm J, Chrisiansen C. 1978 Relationship between hemoglobin and serum testosterone in normal children and adolescents and in boys with delayed puberty. Acta Paediatr Scand. 67:655-658.
31. Krauss DJ, Taub HA, Lantinga LJ, Dunsky MH, Kelly CM. 1991 Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol. 146:1566-1570.
32. Shahidi NT. 1973 Androgens and erythropoiesis. N Engl J Med. 289:72-80.
33. Wilson JD, Griffin JE. 1980 The use and misuse of androgens. Metabolism. 29:1278-1295.
34. Henderson BE, Ross RK, Pike MC, Casagrande JT. 1982 Endogenous hormones as a major factor in human cancer. Cancer Res. 42:3232-3239.
35. Behre HM, Bohmeyer J, Nieschlag E. 1994 Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf). 40:341-349.
36. Bagatell CJ, Heiman JR, Matsumoto AM. 1994 Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab. 79:561-567.
37. Zmuda JM, Fahrenbachum MC, Younkin BT, et al. 1993 The effects of testosterone aromatization on high-density lipoprotein cholesterol levels and post-heprin lipolytic activity. Metabolism. 42:446-450.
38. Friedle KE, Hannan C, Jones RE, et al. 1990 High-density lipoprotein is not decreased if an aromatizable androgen is administered. Metabolism. 39:69-77.
39. Sih R, Morley JE, Kaiser FE, et al. 1997 Testosterone replacement in older hypogonadal men - a 12-month randomized controlled trial. J Clin Endocrinol Metab. 82:1661-1667.
40. Matsumoto AM, Sandblom RE, Schoene RB, et al. 1985 Testosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives, and sleep. Clin Endocrinol (Oxf). 22:713-721.
41. Matsumoto AM. 1994 Hormone therapy of male hypogonadism. Endocrinol Metab Clin North Am. 23:857-875.